Juan M. Melero-Martin

Cryopreservation and in vitro expansion of chondroprogenitor cells isolated from the superficial zone of articular cartilage.

Optimal in-vitro expansion of chondroprogenitor cells in monolayer culture.

Expansion of chondroprogenitor cells on macroporous microcarriers as an alternative to conventional monolayer systems.

Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin.

Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2.

In vivo vasculogenic potential of human blood-derived endothelial progenitor cells.

Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells.

Chapter 13. An in vivo experimental model for postnatal vasculogenesis.

In vivo monitoring of function of autologous engineered pulmonary valve.

Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo.

Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors.

Functional endothelial progenitor cells from cryopreserved umbilical cord blood.

Vascular Stem Cells and Tumor Angiogenesis.

Adult mouse epicardium modulates myocardial injury by secreting paracrine factors.

Concise review: Vascular stem cells and tumor angiogenesis.

Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes.

Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release.

Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature.